Thirdly, the class of GLP1-RA medications are restricted within the VHA system and require pharmacy approval or endocrinology consultation 48 , which may have resulted in potential heterogeneity between the GLP1-RA and DPP4i group
It's a small detail, but its a profoundly important one
Theyre cleared by general proteolysis throughout the body
Cardiovascular outcomes The adjusted mean change in systolic blood pressure (SBP) in the semaglutide group was 3.9 mm Hg (s.e
And when youre eating less overall, its easy to forget about drinking enough water
Krajnc N, Itariu B, Macher S, Marik W, Harreiter J, Michl M, Novak K, Wober C, Pemp B, Bsteh G (2023) Treatment with GLP-1 receptor agonists is associated with significant weight loss and favorable headache outcomes in idiopathic intracranial hypertension